市场调查报告书
商品编码
1521120
2024-2032 年依照明设备类型(发光二极体、雷射)、应用、最终用户和地区分類的光遗传学市场报告Optogenetics Market Report by Light Equipment Type (Light-emitting Diode, Laser), Application, End User, and Region 2024-2032 |
IMARC Group年全球光遗传学市场规模达448亿美元。
光遗传学是指结合遗传学和光学技术的科学方法。它主要用于透过光感测器控制和监测神经元和其他类型细胞的生物功能。这些资讯提供了对个人行为和生理学的深入了解,包括运动、学习、记忆、导航、新陈代谢、呼吸和感测器处理。光遗传学透过揭示与各种疾病相关的细胞活动来帮助临床发现,例如慢性疼痛、癫痫、帕金森氏症、中风、毒瘾、强迫症(OCD)、社交功能障碍以及焦虑和忧郁。由于这些应用,光遗传学在神经科学领域中得到了广泛的应用。
由于各种感染、疾病、遗传性疾病、先天性异常以及大脑、神经和脊髓损伤而导致的神经系统疾病的盛行率不断增加,是目前推动光遗传学市场成长的关键因素之一。与此一致的是,引入光纤耦合发光二极体 (LED) 併入植入物中以实现不受束缚的光传输,这是另一个主要的生长诱导因素。此外,神经连接、无线微晶片、感测器、细胞表型分析工具和各种影像工具(如电脑断层扫描(CT)、位置发射断层扫描(PET) 和磁振造影(MRI))的快速技术进步可精确评估器官和组织识别疾病正在推动市场成长。由于其细胞、空间和时间精度,医疗保健专业人员越来越倾向于光遗传学治疗方法,这进一步促进了市场的成长。其他因素包括医疗保健支出的增加、神经科学领域广泛的研发(R&D)活动,以及主要参与者、製药公司和各国政府之间的战略合作,以实施支持推出治疗新药的有利政策神经系统疾病正在为市场创造积极的前景。
The global optogenetics market size reached US$ 44.8 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 158.7 Billion by 2032, exhibiting a growth rate (CAGR) of 14.8% during 2024-2032.
Optogenetics refers to a scientific approach that includes a combination of genetics and optics technologies. It is primarily used for controlling and monitoring the biological functions of neurons and other types of cells with light sensors. This information provides insights into individual behavior and physiology, including movement, learning, memory, navigation, metabolism, respiration, and sensor processing. Optogenetics aids in clinical discoveries by shedding light on the cellular activities associated with various diseases, such as chronic pain, epilepsy, Parkinson disease, stroke, drug addiction, obsessive compulsion disorder (OCD), social dysfunction, and anxiety and depression. On account of these applications, optogenetics finds extensive utilization in the field of neurosciences.
The increasing prevalence of neurological disorders due to various infections, ailments, genetic disorders, congenital abnormalities, and brain, nerve, and spinal cord injuries is one of the key factors currently driving the optogenetics market growth. In line with this, the introduction of fiber-coupled light-emitting diode (LED) for being incorporated into the implants to enable the untethered light delivery is acting as another major growth-inducing factor. Additionally, rapid technological advancements in neural connectivity, wireless microchip, sensors, cell phenotyping tools, and various imaging tools, like computed tomography (CT), position emission tomography (PET), and magnetic resonance imaging (MRI) to precisely evaluate organs and tissues for identifying disorders is propelling the market growth. The rising inclination of healthcare professionals toward optogenetic therapeutic methodologies on account of its cellular, spatial, and temporal precision is further contributing to the market growth. Other factors, including increasing healthcare expenditure, extensive research and development (R&D) activities in the field of neurosciences, and strategic collaborations between key players, pharmaceutical companies, and governments of various nations to implement favorable policies that support the launch of novel drugs for treating neurological diseases, are creating a positive outlook for the market.
IMARC Group provides an analysis of the key trends in each sub-segment of the global optogenetics market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on light equipment type, application and end user.
Light-emitting Diode (LED)
Laser
Neuroscience
Behavioral Tracking
Retinal Disease Treatment
Others
Hospitals
Clinics
Diagnostic
Research
Others
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
The competitive landscape of the industry has also been examined along with the profiles of the key players being Addgene, Coherent Inc., Elliot Scientific Limited, GenSight Biologics S.A., HUBNER GmbH & Co KG, Judges Scientific plc, Laserglow Technologies, Noldus Information Technology, Regenxbio Inc., Shanghai Laser & Optics Century Co. Ltd, The Jackson Laboratory and Thorlabs Inc.